Article info
PostScript
Letter
Composition, diversity and potential utility of intervention-naïve pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound
- Correspondence to Dr Ferga C Gleeson, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55901, USA; gleeson.ferga{at}mayo.edu
Citation
Composition, diversity and potential utility of intervention-naïve pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound
Publication history
- Received January 3, 2021
- Revised February 24, 2021
- Accepted March 14, 2021
- First published March 22, 2021.
Online issue publication
May 11, 2022
Article Versions
- Previous version (11 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.